DIA:CONN P8(Smart Insulin Pen) Study in Diabetes Patients - Trial NCT06406439
Access comprehensive clinical trial information for NCT06406439 through Pure Global AI's free database. This phase not specified trial is sponsored by G2e Co., Ltd and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
G2e Co., Ltd
Timeline & Enrollment
N/A
May 09, 2024
Dec 01, 2024
Primary Outcome
Change in HbA1c(%) at 12 weeks compared to baseline
Summary
A Multicenter, Open label, Randomized, Comparative Study to Evaluate the Efficacy and Safety
 of Electric Smart Insulin Pen DIA:CONN P8 in patients with Type 1, Type 2 or Pancreatogenic
 Diabetes Mellitus under Multiple Dose Insulin Therapy
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06406439
Device Trial